182 related articles for article (PubMed ID: 29703186)
1. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
Rabachini T; Boccardo E; Andrade R; Perez KR; Nonogaki S; Cuccovia IM; Villa LL
BMC Cancer; 2018 Apr; 18(1):485. PubMed ID: 29703186
[TBL] [Abstract][Full Text] [Related]
2. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
5. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
[TBL] [Abstract][Full Text] [Related]
6. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
8. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
[TBL] [Abstract][Full Text] [Related]
9. miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes.
McKenna DJ; Patel D; McCance DJ
Virology; 2014 Jan; 448():210-6. PubMed ID: 24314651
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
11. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
[TBL] [Abstract][Full Text] [Related]
13. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
[TBL] [Abstract][Full Text] [Related]
14. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.
Bienkowska-Haba M; Luszczek W; Zwolinska K; Scott RS; Sapp M
J Virol; 2020 Jan; 94(3):. PubMed ID: 31748387
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous human papillomavirus E7 type-specific effects on differentiation and proliferation of organotypic skin cultures.
Westphal K; Akgül B; Storey A; Nindl I
Cell Oncol; 2009; 31(3):213-26. PubMed ID: 19478389
[TBL] [Abstract][Full Text] [Related]
18. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein.
Menges CW; Baglia LA; Lapoint R; McCance DJ
Cancer Res; 2006 Jun; 66(11):5555-9. PubMed ID: 16740689
[TBL] [Abstract][Full Text] [Related]
20. IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes.
Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Fiorucci G; Romeo G
Cytokine; 2017 Jan; 89():235-238. PubMed ID: 26748726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
